At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.
By Maureen Salamon and Meredith BegleyFriday, April 8, 2016
The watch and wait approach to treatment, also called active surveillance, is common for lymphomas that pose no immediate threat to a patient’s health. But the tactic can leave some patients initially feeling anxious.
Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.